New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2013
07:45 EDTENDPEndo Health price target lowered to $36 from $42 at Stifel
Stifel reduced its price target on Endo Health after the FDA denied the company's Citizen Petition on OpanaER. The firm was surprised by the FDA's decision ,and thinks the company will now have to restructure, but keeps a Buy rating based on valuation.
News For ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
07:03 EDTENDPEndo price target raised to $110 from $102 at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use